Telesis Bio
Telesis Bio is home to Gibson Assembly, and pioneering synthetic DNA/gene synthesis hardware, including the BioXp, the world’s first DNA printer.
Market cap
$533k
Enterprise value
$56m
Share price
$0.30 TBIO
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | N/A | Post IPO Convertible | |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 68 % | 148 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (228 %) | (307 %) | (170 %) | (107 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (274 %) | (353 %) | (177 %) | (173 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 136 % | 132 % | 86 % | 64 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads